379 related articles for article (PubMed ID: 7516668)
1. Structure of peptides associated with class I and class II MHC molecules.
Engelhard VH
Annu Rev Immunol; 1994; 12():181-207. PubMed ID: 7516668
[TBL] [Abstract][Full Text] [Related]
2. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
3. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
4. Similarity between segments in protein conformational epitopes and MHC II peptides.
Li G; Wu D; Wang S; Sun J; Xu D; Cao Z
Int J Comput Biol Drug Des; 2013; 6(1-2):107-18. PubMed ID: 23428477
[TBL] [Abstract][Full Text] [Related]
5. Structure of peptides associated with MHC class I molecules.
Engelhard VH
Curr Opin Immunol; 1994 Feb; 6(1):13-23. PubMed ID: 7513522
[TBL] [Abstract][Full Text] [Related]
6. Peptide binding by class I and class II MHC molecules.
Batalia MA; Collins EJ
Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
[TBL] [Abstract][Full Text] [Related]
7. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
[TBL] [Abstract][Full Text] [Related]
8. [Interactions between peptides and major histocompatibility complex molecules].
Choppin J
Pathol Biol (Paris); 1992 Mar; 40(3):257-64. PubMed ID: 1376892
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
Agrawal B; Fraga E; Kane K; Singh B
J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
[TBL] [Abstract][Full Text] [Related]
10. Peptide binding to MHC class I and II proteins: new avenues from new methods.
Yaneva R; Schneeweiss C; Zacharias M; Springer S
Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
[TBL] [Abstract][Full Text] [Related]
11. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
Vignali DA; Urban RG; Chicz RM; Strominger JL
Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
[TBL] [Abstract][Full Text] [Related]
12. Peptide interactions with class I and II MHC encoded molecules.
Pecht I
Isr J Med Sci; 1994 Mar; 30(3):28-31. PubMed ID: 7514162
[No Abstract] [Full Text] [Related]
13. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
16. Identification of T-cell epitopes using allele-specific ligand motifs.
Stevanović S; Rammensee HG
Behring Inst Mitt; 1994 Dec; (95):7-13. PubMed ID: 7538751
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire.
Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU
Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258
[TBL] [Abstract][Full Text] [Related]
18. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
19. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
20. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]